Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 3Glioma 2Glioblastoma 2Brain Neoplasms 2Recurrence 1Oligodendroglioma 1Neoplasms 1Lymphoma, Follicular 1Astrocytoma 1

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 16pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioma × Ketoconazole × CNS × Clear all
NCT03796273 2026-03-20

Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
15 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT03763396 2024-03-08

Azoles Targeting Recurrent High Grade Gliomas

University Health Network, Toronto

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡